HOME >> BIOLOGY >> NEWS
Cutting-edge cancer researchers sought for international recognition

The American Association for Cancer Research now is accepting nominations for the fourth annual Kirk A. and Dorothy P. Landon Foundation-AACR Prizes.

These two major international prizes recognize seminal basic and translational cancer research discoveries at the cutting edge of scientific novelty and significance. Eligible candidates are active, recently published scientists who have made extraordinary advances in cancer research, and whose scientific innovation and creativity have contributed to new directions in these fields.

The nomination process and other details about the prizes are located on the AACR Website at http://www.aacr.org. The nomination deadline is Tuesday, August 10, 2004.

The recipient of each prize will receive an unrestricted cash award of $200,000. Both will present lectures during the 96th AACR Annual Meeting, April 16-20, 2005, in Anaheim, Calif., to stimulate and inspire their colleagues to new thinking and fresh approaches in both basic and translational cancer research.

"The Landon-AACR Prizes offer an unprecedented opportunity to recognize the best work of the top cancer research scientists today," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "We are honored to work with the Landon Foundation in sponsoring these distinguished prizes.

R. Kirk Landon, President of the Kirk A. and Dorothy P. Landon Foundation, said, "It is the goal of the foundation to bring heightened public attention to landmark achievements in the continuing effort to prevent and cure cancer. The dynamic lectures given during the AACR Annual Meeting are the perfect forum for promoting and rewarding outstanding cancer research and for motivating cancer investigators around the world. The Kirk A. and Dorothy P. Landon Foundation has been delighted with our synergistic partnership with the AACR and looks forward to honoring the accomplishments of scientists in the y
'"/>

Contact: Elizabeth Tait
tait@aacr.org
215-440-9300
American Association for Cancer Research
23-Jul-2004


Page: 1 2

Related biology news :

1. Cutting-edge research to be presented at ASCPT pharmacology conference
2. Leader in cancer treatment and prevention research honored
3. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
4. Chemical derived from vitamin-E shows early promise as cancer drug
5. New molecular link key to cellular proteins involved in cancer progression, other diseases
6. Phase II trials of second-generation antisense cancer drug planned following successful early study
7. Trial shows which brain cancer patients benefit from temozolomide
8. Genetic differences might help distinguish thyroid cancers
9. Evidence builds for potential new cancer drug target
10. New sequence involved in DNA replication timing may aid in cancer detection
11. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/5/2020)... ... ... “Although we are disappointed to have to make this decision our primary ... We remain committed to creating a global platform to showcase the science, and ... of WMIS. , The abstract deadline for the virtual meeting is ...
(Date:6/2/2020)... ... June 02, 2020 , ... ... barcode and RFID labeling software developer and solutions provider, today reported that ... improved labeling accuracy and compliance by 100%, resulting in greater efficiency for ...
(Date:5/28/2020)... (PRWEB) , ... May 27, 2020 , ... CrucialTrak, a ... partner with New Jersey-based Critical Environments Group (CEG) to market and sell its complete ... of data center and IT environment infrastructure optimization solutions . , Brett ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... ... (PTU) is commonly used to suppress pigment formation in zebrafish embryos, maintaining optical ... team led by Dr MA has been using the zebrafish model to investigate ...
(Date:7/7/2020)... ... 06, 2020 , ... R3 International is now offering stem cell therapy for ... cells. Depending on the patient's condition, treatment may be offered IV, intrathecal or with ... form of Alzheimers dementia, and the incidence continues to increase as individuals live longer. ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... growth of 40% in 2020, despite many obstacles created as a result of ... increase revenue for its partnered medical practices and medical manufacturers by expanding access ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... launch of a new clinical diagnostics immuno-oncology service, TissueInsight . TissueInsight ... , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, and immunologists ...
Breaking Biology Technology:
Cached News: